Since its inception in 1995, Perseus has invested in numerous buyout and growth equity transactions in the United States, Canada, and Western Europe. Perseus manages seven investment funds with capital commitments totaling approximately $2.0 billion. In addition, Perseus co-manages a $449 million fund that invests exclusively in life sciences companies.